Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SCHEDULE – M – Revised

How Schedule M (Revised) GMP Promotes Sustainability in Pharmaceutical Manufacturing

Posted on December 21, 2024 By digi

How Schedule M (Revised) GMP Promotes Sustainability in Pharmaceutical Manufacturing Embracing Sustainability in Pharmaceutical Manufacturing Through Schedule M (Revised) GMP Introduction to Sustainability in Pharmaceutical Manufacturing Sustainability has become a cornerstone of modern pharmaceutical manufacturing, addressing the environmental, economic, and social challenges associated with the industry. Recognizing this, Schedule M (Revised) under the Drugs and…

Read More “How Schedule M (Revised) GMP Promotes Sustainability in Pharmaceutical Manufacturing” »

SCHEDULE - M - Revised

The Impact of Schedule M (Revised) GMP on the Pharmaceutical Industry in India

Posted on December 22, 2024 By digi

The Impact of Schedule M (Revised) GMP on the Pharmaceutical Industry in India How Schedule M (Revised) GMP is Shaping the Pharmaceutical Industry in India Introduction to Schedule M (Revised) and Its Significance The pharmaceutical industry in India is one of the largest in the world, known for its high-quality generic medicines and affordable healthcare…

Read More “The Impact of Schedule M (Revised) GMP on the Pharmaceutical Industry in India” »

SCHEDULE - M - Revised

How to Implement Lean Manufacturing in Compliance with Schedule M (Revised) GMP

Posted on December 23, 2024 By digi

How to Implement Lean Manufacturing in Compliance with Schedule M (Revised) GMP Strategies to Implement Lean Manufacturing While Complying with Schedule M (Revised) GMP Introduction to Lean Manufacturing and Schedule M (Revised) Lean manufacturing is a methodology that focuses on minimizing waste and maximizing efficiency without compromising product quality. In the pharmaceutical industry, implementing lean…

Read More “How to Implement Lean Manufacturing in Compliance with Schedule M (Revised) GMP” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Influences Drug Development and Manufacturing Processes

Posted on December 23, 2024 By digi

How Schedule M (Revised) GMP Influences Drug Development and Manufacturing Processes The Role of Schedule M (Revised) GMP in Shaping Drug Development and Manufacturing Introduction to Schedule M (Revised) in Drug Development Drug development and manufacturing are critical processes that require precision, compliance, and a commitment to quality. Schedule M (Revised) under the Drugs and…

Read More “How Schedule M (Revised) GMP Influences Drug Development and Manufacturing Processes” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Enhances Risk Management in Pharma Manufacturing

Posted on December 24, 2024 By digi

How Schedule M (Revised) GMP Enhances Risk Management in Pharma Manufacturing Strengthening Risk Management in Pharmaceutical Manufacturing with Schedule M (Revised) GMP Introduction to Risk Management in Pharmaceutical Manufacturing In pharmaceutical manufacturing, managing risks is essential to ensure product quality, patient safety, and regulatory compliance. Risks can arise at various stages, from raw material procurement…

Read More “How Schedule M (Revised) GMP Enhances Risk Management in Pharma Manufacturing” »

SCHEDULE - M - Revised

Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars

Posted on December 25, 2024 By digi

Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars Ensuring Quality and Compliance in the Manufacture of Biologics and Biosimilars Under Schedule M (Revised) GMP Introduction to Biologics, Biosimilars, and Schedule M (Revised) Biologics and biosimilars are among the most advanced pharmaceutical products, offering targeted treatments for diseases such as cancer, autoimmune disorders,…

Read More “Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars” »

SCHEDULE - M - Revised

Best Practices for Achieving and Maintaining Schedule M (Revised) GMP Compliance

Posted on December 25, 2024 By digi

Best Practices for Achieving and Maintaining Schedule M (Revised) GMP Compliance Proven Strategies for Achieving and Sustaining Schedule M (Revised) GMP Compliance Introduction to Schedule M (Revised) GMP Compliance Schedule M (Revised) under the Drugs and Cosmetics Act, 1940, outlines comprehensive Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and quality of pharmaceutical products…

Read More “Best Practices for Achieving and Maintaining Schedule M (Revised) GMP Compliance” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Guidelines Ensure Safety in the Manufacturing of Injectable Products

Posted on December 26, 2024 By digi

How Schedule M (Revised) GMP Guidelines Ensure Safety in the Manufacturing of Injectable Products Ensuring Safety in Injectable Manufacturing with Schedule M (Revised) GMP Guidelines Introduction to Injectable Manufacturing and GMP Injectable products are critical in healthcare, offering rapid and targeted delivery of medications directly into the bloodstream or tissues. However, the complexity of their…

Read More “How Schedule M (Revised) GMP Guidelines Ensure Safety in the Manufacturing of Injectable Products” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Standards Support Generic Drug Manufacturing in India

Posted on December 27, 2024 By digi

How Schedule M (Revised) GMP Standards Support Generic Drug Manufacturing in India Enhancing Generic Drug Manufacturing in India with Schedule M (Revised) GMP Standards Introduction to Generic Drug Manufacturing in India India is renowned as the “pharmacy of the world,” with a significant share in the global generic drug market. Generic drugs provide affordable healthcare…

Read More “How Schedule M (Revised) GMP Standards Support Generic Drug Manufacturing in India” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Influences Pharma Packaging and Labeling Compliance

Posted on December 28, 2024 By digi

How Schedule M (Revised) GMP Influences Pharma Packaging and Labeling Compliance Ensuring Packaging and Labeling Compliance Through Schedule M (Revised) GMP Guidelines Introduction to Pharma Packaging and Labeling Pharmaceutical packaging and labeling are critical components of drug manufacturing, directly impacting product safety, stability, and patient information. The packaging protects the drug from contamination and degradation,…

Read More “How Schedule M (Revised) GMP Influences Pharma Packaging and Labeling Compliance” »

SCHEDULE - M - Revised

Posts pagination

Previous 1 2 3 4 5 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme